Viewing Study NCT00831103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-06-06 @ 10:32 AM
Study NCT ID: NCT00831103
Status: COMPLETED
Last Update Posted: 2013-12-05
First Post: 2009-01-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster
Sponsor: Epiphany Biosciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Herpes Zoster View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EPB348 View
None Valomaciclovir Stearate View
None Valacyclovir View
None Herpes Zoster View
None Shingles View